Performances on the Montreal Cognitive Assessment Along the Cardiovascular Disease Continuum | Zendy

Christine Gag | Zendy; Kathia Saillant | Zendy; Miloudza Olmand | Zendy; Mathieu Gayda | Zendy; Anil Nigam | Zendy; Nadia Bouabdallaoui | Zendy; JeanLucien Rouleau | Zendy; Laurence Desjardins-Crépeau | Zendy; Louis Bherer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Performances on the Montreal Cognitive Assessment Along the Cardiovascular Disease Continuum

Author(s) -

Christine Gag,

Kathia Saillant,

Miloudza Olmand,

Mathieu Gayda,

Anil Nigam,

Nadia Bouabdallaoui,

JeanLucien Rouleau,

Laurence Desjardins-Crépeau,

Louis Bherer

Publication year - 2021

Publication title -

archives of clinical neuropsychology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.909

H-Index - 98

eISSN - 1873-5843

pISSN - 0887-6177

DOI - 10.1093/arclin/acab029

Subject(s) - montreal cognitive assessment , heart failure , framingham risk score , verbal fluency test , medicine , cardiology , disease , neuropsychology , cognition , dementia , physical therapy , psychiatry

Cardiovascular diseases involve a continuum starting with risk factors, which can progress to coronary heart disease and eventually, to heart failure. Cognitive impairment (CI) is observed as early as cardiovascular risk factors, and in up to 50% of patients with heart failure. Because CI in cardiovascular disease is linked to poorer clinical outcomes, early detection is essential. The Montreal Cognitive Assessment (MoCA) is a screening tool widely used in clinical setting. To date, little is known about MoCA scores along the cardiovascular disease continuum.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research